Clinical Research

Clinical Trials Drug Approval FDA Chronic Conditions Cognitive Function Neurology Women's Health Chronic Conditions Medical Treatments Infectious Diseases

Migraine Drug Ubrogepant Found to Ease Early Symptoms Before Headache Onset

Phase III trial reveals modest improvements in fatigue, light sensitivity, and neck pain when ubrogepant is taken during the prodrome phase.

FDA Approves First New Oral Antibiotic for UTIs in Nearly 30 Years